Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria. NORASEPT II Study Investigators.
Marik
P E
PE
Department of Medicine, Washington Hospital Center, DC 20010-2975, USA.
Iglesias
J
J
D058186:Acute Kidney Injury / Q000209:etiology* / Q000401:mortality / Q000517:prevention & control*; D000328:Adult; D000704:Analysis of Variance; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016009:Chi-Square Distribution; D004298:Dopamine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009846:Oliguria / Q000150:complications*; D016032:Randomized Controlled Trials as Topic; D012772:Shock, Septic / Q000150:complications*; D016019:Survival Analysis; D016896:Treatment Outcome
D002316:Cardiotonic Agents; D004298:Dopamine